Although the regulations offer straightforward grounds for challenging the fanciful transfer pricing method endorsed in Medtronic II, a potential appeal could shed light on broader questions about the ...
The comparable profits method is still often cast as uniquely conceptually flawed among transfer pricing methods and only suitable for use as a last resort, but this characterization often draws ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback